Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan

被引:49
|
作者
Ismail, Mohammad [1 ]
Iqbal, Zafar [1 ]
Khattak, Muhammad Bilal [2 ]
Khan, Muhammad Imran [2 ]
Arsalan, Hassan [3 ]
Javaid, Arshad [4 ]
Gul, Qamar [5 ]
Khan, Faramoz [6 ]
机构
[1] Univ Peshawar, Dept Pharm, Peshawar, Khyber Pakhtunk, Pakistan
[2] Ayub Teaching Hosp, Ayub Med Coll, Abbottabad, Khyber Pakhtunk, Pakistan
[3] Sarhad Univ Sci & Informat Technol, Dept Pharm, Peshawar, Pakistan
[4] LRH, PGMI, Peshawar, Pakistan
[5] Univ Malakand, Dept Pharm, Chakdara, Khyber Pakhtunk, Pakistan
[6] Khyber Teaching Hosp, Med Unit B, Peshawar, Pakistan
关键词
Adverse drug interaction; Clinical pharmacy; Drug related problem; Pakistan; Potential drug-drug interaction; Prescriptions screening;
D O I
10.1007/s11096-013-9764-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Multiple drugs therapies may be the potential source of drug-drug interactions that can result in alteration of therapeutic response and/or increase untoward effects of many drugs. Objective To identify the frequency and levels of potential drug-drug interactions (pDDIs) in internal medicine wards and their association with patients' age, gender, length of hospital stay and number of prescribed medications; and to describe management of frequently identified major or moderate pDDIs. Setting Internal medicine wards of two major tertiary care hospitals of Khyber Pakhtunkhwa, Pakistan. Method Micromedex Drug-Reax system was used to screen patient's profiles for pDDIs. Logistic regression was applied to determine the odds ratio for specific risk factors of pDDIs i.e., age, gender, hospital-stay and number of medications. Main outcome measure Overall prevalence and prevalence of contraindicated, major, moderate and minor pDDIs; levels of pDDIs; frequently identified major or moderate interactions; and odds ratios for risk factors. Results Total, 188 interacting drug-combinations were identified that contributed to 675 pDDIs. Of 400 patients, 52.8 % patients were presented with at least one pDDI (overall prevalence), 21.3 % with at least one major-pDDI, and 44.3 % with at least one moderate-pDDI. Of 675 pDDIs, most were of moderate (63.6 %) or major severity (23 %); good (61.2 %) or fair (25.5 %) type of scientific evidence; and delayed onset (50.2 %). Most frequently identified major or moderate interactions resulted in 45.3 % of all pDDIs. Their potential adverse outcomes included hepatotoxicity, bleeding, ototoxicity, nephrotoxicity, hypoglycemia, hyperglycemia, risk of thrombosis, hypotension, cardiac arrhythmias and reduction in therapeutic-effectiveness. There was significant association of the occurrence of pDDIs with patients' age of 60 years or more (OR = 2.1; 95 % CI = 1.3-3.3; p = 0.003), hospital stay of 6 days or longer (OR = 2.6; 95 % CI = 1.5-4.5; p = 0.001), and seven or more number of prescribed medications (OR = 5.9; 95 % CI = 3.6-9.6; p < 0.001). Conclusion The present study has recorded a high prevalence of pDDIs in internal medicine wards. Patients with old age, longer hospital stay and increased number of prescribed medications were at higher risk.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 50 条
  • [21] Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan
    Ismail, Mohammad
    Khan, Farmanullah
    Noor, Sidra
    Haider, Iqbal
    Inam-ul Haq
    Ali, Zahid
    Shah, Zahir
    Hassam, Mohsin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (05) : 1052 - 1056
  • [22] Frequency, Levels and Predictors of Potential Drug-Drug Interactions in a Pediatrics Ward of a Teaching Hospital in Pakistan
    Ismail, Mohammad
    Iqbal, Zafar
    Khan, Muhammad I.
    Javaid, Arshad
    Arsalan, Hassan
    Farhadullah
    Khan, Faramoz
    Khan, Amir Z.
    Nasir, Fazli
    Khan, Jamshaid A.
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2013, 12 (03) : 401 - 406
  • [23] Detection and evaluation of drug-drug interactions in an internal medicine service
    Roldan-Daviu, A.
    Javier, I.
    Modamio, P.
    El Hilali, N.
    Lastra, C. F.
    Aguas, M.
    Marino, E. L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 942 - 942
  • [24] DRUG-DRUG INTERACTIONS IN HOSPITAL
    MOK, H
    MULPETER, K
    OCONNOR, P
    FEELY, J
    IRISH MEDICAL JOURNAL, 1991, 84 (01) : 26 - 26
  • [25] Evaluation of potential drug-drug interactions among patients of the nephrology and kidney transplant wards of a major teaching hospital
    Khamas, Shahriyar Shahbazi
    Jafari, Atefeh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 223 - 223
  • [26] Determination of potential drug-drug interactions by using various drug interaction software programs at hospital pharmacy setting
    Kuyumciyan, T.
    Okuyan, B.
    Cilingiroglu, M.
    Sancar, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 550 - 551
  • [27] POTENTIAL DRUG-DRUG INTERACTIONS IN OUTPATIENT PRESCRIPTIONS IN A GENERAL HOSPITAL
    Maria, A.
    Nicoletta, K.
    Pantelis, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 156 - 157
  • [29] Potential drug-drug interactions in cardiology ward of a teaching hospital
    Ismail, Mohammad
    Iqbal, Zafar
    Khattak, Muhammad Bilal
    Khan, Muhammad Imran
    Javaid, Arshad
    Khan, Tahir Mehmood
    HEALTHMED, 2012, 6 (05): : 1618 - 1624
  • [30] Highlighting the potential frequency of drug-drug interactions with PAXLOVID™ in an Irish setting
    Mac Avin, M. J.
    O'Malley, G.
    Smith, A.
    Clarke, S.
    Barry, M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 23 - 24